References
- Basu S. Ocular Tuberculosis. In: Rao NA, Schallhorn J, Rodger DC, eds., Posterior Uveitis. Cham: Springer; 2019:115–124.
- Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;4:121–125.
- Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)–1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:https://doi.org/10.1001/jamaophthalmol.2017.4485.
- Smit DP, Esterhuizen TM, Meyer D. The prevalence of intraocular tuberculosis in HIV-positive and HIV-negative patients in South Africa using a revised classification system. Ocul Immunol Inflamm. 2018;26(6):830. doi:https://doi.org/10.1080/09273948.2016.1263342.
- Krassas N, Wells J, Bell C, Woodhead M, Jones N. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area. Eye (Lond). 2018;32(1):87–92. doi:https://doi.org/10.1038/eye.2017.152.
- Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118(4):772–777. doi:https://doi.org/10.1016/j.ophtha.2010.08.011.
- Young D. Animal models of tuberculosis. Eur J Immunol. 2009;39(8):2011–2014. doi:https://doi.org/10.1002/eji.200939542.
- Sánchez-Garibay C, Hernández-Campos ME, Tena-Suck ML, Salinas-Lara C. Experimental animal models of central nervous system tuberculosis: A historical review. Tuberculosis. 2018;110:1–6. doi:https://doi.org/10.1016/j.tube.2018.02.007.
- Verhoeff FH. The experimental production of sclerokeratitis and chronic intraocular tuberculosis. Trans Am Ophthalmol Soc. 1913;13:469.
- Ohmart WA. Experimental tuberculosis of the eye. Am J Ophthalmol. 1933;16(9):773–778. doi:https://doi.org/10.1016/S0002-9394(33)94719-4.
- Woods AC. Experimental studies on the pathogenesis and treatment of ocular tuberculosis. Br J Ophthalmol. 1949;33(4):197. doi:https://doi.org/10.1136/bjo.33.4.197.
- Stock W. Retinal haemorrhage due to miliary tuberculosis. Klin M Monalsol Augeuh. 1937;99:367.
- Finnoff WC. Changes in eyes of rabbits following injection of dead tubercle bacilli into common carotid artery. Am J Ophthalmol. 2012;7:365–372. doi:https://doi.org/10.1016/S0002-9394(24)90818-X.
- Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol. 2012;12(3):215–225. doi:https://doi.org/10.1038/nri3167.
- Zwadyk P, Down JA, Myers N, et al. Rendering of mycobacteria safe for molecular diagnostic studies and development of a lysis method for strand displacement amplification and PCR. J Clin Micobiol. 1994;32(9):2140–2146. doi:https://doi.org/10.1128/JCM.32.9.2140-2146.1994.
- Rao NA, Albini TA, Kumaradas M, Pinn ML. Fraig MM and Karakousis PC. Experimental ocular tuberculosis in guinea pigs. Arch Ophthalmol. 2009;127:1162–1166. doi:https://doi.org/10.1001/archophthalmol.2009.220.
- Ahmad Z, Fraig MM, Bisson GP, Nuermberger EL, Grosset JH, Karakousis PC. Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections. Antimicrob Agents Chemother. 2011;55(4):1527–1532. doi:https://doi.org/10.1128/AAC.01524-10.
- Tezera LB, Mansour S, Elkington P. Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2020;201(4):407–413. doi:https://doi.org/10.1164/rccm.201908-1506PP.
- Thayil SM, Albini TA, Nazari H, et al. Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PloS One. 2011;6(12):e28383. doi:https://doi.org/10.1371/journal.pone.0028383.
- Via LE, Lin PL, Ray SM, et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun. 2008;76(6):2333–2340. doi:https://doi.org/10.1128/IAI.01515-07.
- Belton M, Brilha S, Manavaki R, et al. Hypoxia and tissue destruction in pulmonary TB. Thorax. 2016;71(12):1145–1153. doi:https://doi.org/10.1136/thoraxjnl-2015-207402.
- Oehlers SH, Cronan MR, Scott NR, et al. Interception of host angiogenic signalling limits mycobacterial growth. Nature. 2015;517(7536):612. doi:https://doi.org/10.1038/nature13967.
- Cadena AM, Flynn JL, Fortune SM. The importance of first impressions: early events in Mycobacterium tuberculosis infection influence outcome. MBio. 2016;7(2):e00342–16. doi:https://doi.org/10.1128/mBio.00342-16.
- Takaki K, Davis JM, Winglee K, Ramakrishnan L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nat Protoc. 2013;8(6):1114. doi:https://doi.org/10.1038/nprot.2013.068.
- Pagán AJ, Ramakrishnan L. Immunity and immunopathology in the tuberculous granuloma. Cold Spring Harb Perspect Med. 2015;5(9):a018499. doi:https://doi.org/10.1101/cshperspect.a018499.
- Takaki K, Ramakrishnan L, Basu S. A zebrafish model for ocular tuberculosis. PloS One. 2018;13(3):e0194982. doi:https://doi.org/10.1371/journal.pone.0194982.
- Abhishek S, Gupta A, Verma I. Experimental mouse model of tuberculous uveitis. BMC Infect Dis. 2014;14(Suppl 3):O20. doi:https://doi.org/10.1186/1471-2334-14-S3-O20.
- Abhishek S, Saikia UN, Gupta A. et al. Transcriptional profile of Mycobacterium tuberculosis in an in vitro model of intraocular tuberculosis. Front Cell Infect Microbiol. 2018;8:330. doi:https://doi.org/10.3389/fcimb.2018.00330.
- Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis. Methods Mol Biol. 2012;900:443–469.
- Chen J, Qian H, Horai R, Chan CC, Falick Y, Caspi RR. Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein. PloS One. 2013;8(8):e72161. doi:https://doi.org/10.1371/journal.pone.0072161.
- Diedrichs-Moehring M, Kaufmann U, Wildner G. The immunopathogenesis of chronic and relapsing autoimmune uveitis–lessons from experimental rat models. Prog Retin Eye Res. 2018;65:107–126. doi:https://doi.org/10.1016/j.preteyeres.2018.02.003.
- Forrester JV, Kuffova L, Dick AD. Autoimmunity, autoinflammation, and infection in uveitis. Am J Ophthalmol. 2018;189:77–85. doi:https://doi.org/10.1016/j.ajo.2018.02.019.
- Pepple KL, Rotkis L, Van Grol J, et al. Primed mycobacterial uveitis (PMU): histologic and cytokine characterization of a model of uveitis in rats. Invest Ophthalmol Vis Sci. 2015;56(13):8438–8448. doi:https://doi.org/10.1167/iovs.15-17523.
- Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Inves Ophthalmol Vis Sci. 1995;36(2):442–453.
- Gonzalez OY, Musher DM, Brar I, et al. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003;36(2):140–148. doi:https://doi.org/10.1086/344908.
- Gerbrandy SJ, Schreuders LC, De Smet MD. Mycobacterium bovis endophthalmitis from BCG immunotherapy for bladder cancer. Ocul Immunol Inflamm. 2008;16(3):95–97. doi:https://doi.org/10.1080/09273940802056273.
- Garip A, Diedrichs-Möhring M, Thurau SR, Deeg CA, Wildner G. Uveitis in a patient treated with Bacille-Calmette-Guerin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology. 2009;116(12):2457–2462. doi:https://doi.org/10.1016/j.ophtha.2009.05.021.
- Brites D, Gagneux S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol Rev. 2015;264(1):6–24. doi:https://doi.org/10.1111/imr.12264.
- Elkington P, Lerm M, Kapoor N, et al. In Vitro Granuloma Models of Tuberculosis: potential and Challenges. J Infect Dis. 2019;219(12):1858–1866.doi:https://doi.org/10.1093/infdis/jiz020.
- Sridhar A, Langer KB, Fligor CM, et al. Human pluripotent stem cells as In Vitro models for retinal development and disease. In: Ballios BG, Young MJ, eds. Regenerative Medicine and Stem Cell Therapy for the Eye. Cham: Springer; 2018:17–49.
- Shafaie S, Hutter V, Cook MT, Brown MB, Chau DY. In Vitro cell models for ophthalmic drug development applications. Biores Open Access. 2016;5(1):94–108. doi:https://doi.org/10.1089/biores.2016.0008.
- Sugimura R, Jha DK, Han A, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545(7655):432–438. doi:https://doi.org/10.1038/nature22370.
- Abaci HE, Shuler ML. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. Integr Biol (Camb). 2015;7(4):383–391. doi:https://doi.org/10.1039/c4ib00292j.
- Bielecka MK, Tezera LB, Zmijan R, et al. A bioengineered three-dimensional cell culture platform integrated with microfluidics to address antimicrobial resistance in tuberculosis. mBio. 2017;8(1):e02073–16.doi:https://doi.org/10.1128/mBio.02073-16.
- Prendergast RA, Iliff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. IOVS. 1998;39(5):754–762.
- Horai R, Zárate-Bladés CR, Dillenburg-Pilla P, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43(2):343–353. doi:https://doi.org/10.1016/j.immuni.2015.07.014.